Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S2W-29092 · Session 2

Whether it will monitor the number of patients who choose to purchase donepezil, galantamine and rivastigmine privately for mild Alzheimer’…

Answered Asked by Euan Robson LD Lodged 16 Oct 2006

The question

To ask the Scottish Executive whether it will monitor the number of patients who choose to purchase donepezil, galantamine and rivastigmine privately for mild Alzheimer’s disease.

The answer

Answered by Lewis Macdonald on 10 Nov 2006 · 25 days after it was lodged, on time

Information on private prescriptionsis not collected centrally except for schedule 2 and 3 controlled drugs.

In the Official Report

No contribution in the Official Report cites S2W-29092 by reference.